(Q40915990)

English

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism (English)

1 reference

Europe PubMed Central

24 September 2017

hyperparathyroidism

1 reference

based on heuristic

inferred from title

author name string

A U Tan

1

1 reference

Europe PubMed Central

24 September 2017

B S Levine

2

1 reference

Europe PubMed Central

24 September 2017

R B Mazess

3

1 reference

Europe PubMed Central

24 September 2017

D M Kyllo

4

1 reference

Europe PubMed Central

24 September 2017

C W Bishop

5

1 reference

Europe PubMed Central

24 September 2017

J C Knutson

6

1 reference

Europe PubMed Central

24 September 2017

K S Kleinman

7

1 reference

Europe PubMed Central

24 September 2017

J W Coburn

8

1 reference

Europe PubMed Central

24 September 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

24 September 2017

Kidney International

1 reference

Europe PubMed Central

24 September 2017

51

1 reference

Europe PubMed Central

24 September 2017

1

1 reference

Europe PubMed Central

24 September 2017

317-323

1 reference

Europe PubMed Central

24 September 2017

https://scigraph.springernature.com/pub.10.1038/ki.1997.39

0 references

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression by 1,25(OH)2D3 of transcription of the pre-proparathyroid hormone gene

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Antirachitic Activity of 1α-Hydroxyergocalciferol and 1α-Hydroxycholecalciferol in Rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

1 alpha-Hydroxyvitamin D2 is less toxic than 1 alpha-hydroxyvitamin D3 in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of vitamin D2 analogs on calcium metabolism in vitamin D-deficient rats and in MC3T3-E1 osteoblastic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of increasing doses of 1 alpha-hydroxyvitamin D2 on calcium homeostasis in postmenopausal osteopenic women

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

The spectrum of bone disease in end-stage renal failure--an evolving disorder

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: a randomized prospective trial.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intravenous 1-alpha-hydroxyvitamin D3 on secondary hyperparathyroidism in chronic uremic patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.39

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/KI.1997.39

1 reference

Europe PubMed Central

24 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40915990&oldid=2092570594"